Clinical Trials in Denver

Showing 4661-4680 of 18,161 trials

Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma

NCT03635164

This is a multi-center, prospective, single-arm phase I/Ib safety trial. Patients eligible for treatment must be diagnosed with non-metastatic, biopsy-proven stage II-IVB oral cavity, stage III-IVB larynx and hypopharynx, or stage III-IVB HPV/p16 negative intermediate-high risk oropharynx head and neck cancer, and must be eligible and amenable to surgical resection.

Squamous Cell Carcinoma of the Head and Neck

University of Colorado, Denver21 participantsStarted Nov 2018

Aurora, Colorado, United States • Colorado Springs, Colorado, United States • Fort Collins, Colorado, United States

Active Not RecruitingPhase 18.4 miles

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

NCT04907526

Researchers want to better understand what happens to the heart when the autologous (from one's own body) stem cells are injected directly into muscle of the right side of the heart during the Fontan (Stage III) surgery. They want to see if there are changes in the electrical activity, the structure, and the function of the heart following this stem cell-based therapy. Researchers will compare the results from people who receive the stem cells to the results from people who do not receive the stem cells.

Congenital Heart Disease, SRV Dependent

Timothy J Nelson, MD, PhD30 participantsStarted Jun 2021

Birmingham, Alabama, United States • Los Angeles, California, United States • Aurora, Colorado, United States +3 more locations

Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

Find Trials by Condition in Denver

Adolescent Master Protocol

BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)

Distal Radius Interventions for Fracture Treatment

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Beacon Sensors and Telerehabilitation for Low Vision

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

LTFU for All Cell and Gene Therapy Studies

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

Cough Reduction in IPF With Nalbuphine ER